Weverling-Rijnsburger AW - Search Results

1

Effect of atorvastatin on impaired vascular function in healthy old men.

Weverling-Rijnsburger AW, Blauw GJ, Meinders AE. Weverling-Rijnsburger AW, et al. J Clin Pharm Ther. 2004 Apr;29(2):157-64. doi: 10.1111/j.1365-2710.2004.00548.x. J Clin Pharm Ther. 2004. PMID: 15068405

2

Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin.

de Man FH, Weverling-Rijnsburger AW, van der Laarse A, Smelt AH, Jukema JW, Blauw GJ. de Man FH, et al. Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):744-50. doi: 10.1161/01.atv.20.3.744. Arterioscler Thromb Vasc Biol. 2000. PMID: 10712400 Clinical Trial.

3

Late-onset dementia: structural brain damage and total cerebral blood flow.

Spilt A, Weverling-Rijnsburger AW, Middelkoop HA, van Der Flier WM, Gussekloo J, de Craen AJ, Bollen EL, Blauw GJ, van Buchem MA, Westendorp RG. Spilt A, et al. Among authors: weverling rijnsburger aw. Radiology. 2005 Sep;236(3):990-5. doi: 10.1148/radiol.2363041454. Epub 2005 Jul 12. Radiology. 2005. PMID: 16014443

4

Total cholesterol and risk of mortality in the oldest old.

Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RG. Weverling-Rijnsburger AW, et al. Lancet. 1997 Oct 18;350(9085):1119-23. doi: 10.1016/s0140-6736(97)04430-9. Lancet. 1997. PMID: 9343498

5

Patients with Alzheimer's disease display a pro-inflammatory phenotype.

Remarque EJ, Bollen EL, Weverling-Rijnsburger AW, Laterveer JC, Blauw GJ, Westendorp RG. Remarque EJ, et al. Exp Gerontol. 2001 Jan;36(1):171-6. doi: 10.1016/s0531-5565(00)00176-5. Exp Gerontol. 2001. PMID: 11162920

6

Optimal screening for increased risk for adverse outcomes in hospitalised older adults.

Heim N, van Fenema EM, Weverling-Rijnsburger AW, Tuijl JP, Jue P, Oleksik AM, Verschuur MJ, Haverkamp JS, Blauw GJ, van der Mast RC, Westendorp RG. Heim N, et al. Among authors: weverling rijnsburger aw. Age Ageing. 2015 Mar;44(2):239-44. doi: 10.1093/ageing/afu187. Epub 2014 Nov 28. Age Ageing. 2015. PMID: 25432981 Free PMC article.

7

Cholesterol and all-cause mortality in Honolulu.

Weverling-Rijnsburger AW, Blauw GJ, Westendorp RG. Weverling-Rijnsburger AW, et al. Lancet. 2001 Dec 1;358(9296):1905-6. doi: 10.1016/S0140-6736(01)06909-4. Lancet. 2001. PMID: 11741661 No abstract available.

8

The development, implementation and evaluation of a transitional care programme to improve outcomes of frail older patients after hospitalisation.

Heim N, Rolden H, van Fenema EM, Weverling-Rijnsburger AW, Tuijl JP, Jue P, Oleksik AM, de Craen AJ, Mooijaart SP, Blauw GJ, Westendorp RG, van der Mast RC, van Everdinck IE. Heim N, et al. Among authors: weverling rijnsburger aw. Age Ageing. 2016 Sep;45(5):643-51. doi: 10.1093/ageing/afw098. Epub 2016 Jun 13. Age Ageing. 2016. PMID: 27298381

9

High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.

Weverling-Rijnsburger AW, Jonkers IJ, van Exel E, Gussekloo J, Westendorp RG. Weverling-Rijnsburger AW, et al. Arch Intern Med. 2003 Jul 14;163(13):1549-54. doi: 10.1001/archinte.163.13.1549. Arch Intern Med. 2003. PMID: 12860577

10

Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy.

Mohrschladt MF, Weverling-Rijnsburger AW, de Man FH, Stoeken DJ, Sturk A, Smelt AH, Westendorp RG. Mohrschladt MF, et al. Atherosclerosis. 2000 Feb;148(2):413-9. doi: 10.1016/s0021-9150(99)00316-0. Atherosclerosis. 2000. PMID: 10657578 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page